| ［1］ |
Olsen EA, Abernethy ML, Kulp⁃Shorten C, et al. A double⁃blind, vehicle⁃controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck［J］. J Am Acad Dermatol, 1991,24（5 Pt 1）:738⁃743. doi: 10.1016/0190⁃9622（91）70113⁃g.
|
| ［2］ |
Ibbotson S, Stones R, Bowling J, et al. A consensus on the use of daylight photodynamic therapy in the UK［J］. J Dermatolog Treat, 2017,28（4）:360⁃367. doi: 10.1080/09546634.2016.1240863.
|
| ［3］ |
Werner RN, Stockfleth E, Connolly SM, et al. Evidence⁃ and consensus⁃based （S3） guidelines for the treatment of actinic keratosis ⁃ International League of Dermatological Societies in cooperation with the European Dermatology Forum ⁃ short version［J］. J Eur Acad Dermatol Venereol, 2015,29（11）:2069⁃2079. doi: 10.1111/jdv.13180.
|
| ［4］ |
Nguyen M, Sandhu SS, Sivamani RK. Clinical utility of daylight photodynamic therapy in the treatment of actinic keratosis ⁃ a review of the literature［J］. Clin Cosmet Investig Dermatol, 2019,12:427⁃435. doi: 10.2147/CCID.S167498.
|
| ［5］ |
Ang JM, Riaz IB, Kamal MU, et al. Photodynamic therapy and pain: a systematic review［J］. Photodiagnosis Photodyn Ther, 2017,19:308⁃344. doi: 10.1016/j.pdpdt.2017.07.002.
|
| ［6］ |
Sotiriou E, Evangelou G, Papadavid E, et al. Conventional vs. daylight photodynamic therapy for patients with actinic keratosis on face and scalp: 12⁃month follow⁃up results of a randomized, intra⁃individual comparative analysis［J］. J Eur Acad Dermatol Venereol, 2018,32（4）:595⁃600. doi: 10.1111/jdv.14613.
|
| ［7］ |
Fargnoli MC, Piccioni A, Neri L, et al. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra⁃patient, prospective, comparison study in Italy［J］. J Eur Acad Dermatol Venereol, 2015,29（10）:1926⁃1932. doi: 10.1111/jdv.13076.
|
| ［8］ |
Zhu L, Wang P, Zhang G, et al. Conventional versus daylight photodynamic therapy for actinic keratosis: a randomized and prospective study in China［J］. Photodiagnosis Photodyn Ther, 2018,24:366⁃371. doi: 10.1016/j.pdpdt.2018.10.010.
|
| ［9］ |
Lacour JP, Ulrich C, Gilaberte Y, et al. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator⁃blinded, controlled, phase III study throughout Europe［J］. J Eur Acad Dermatol Venereol, 2015,29（12）:2342⁃2348. doi: 10.1111/jdv.13228.
|
| ［10］ |
Rubel DM, Spelman L, Murrell DF, et al. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial［J］. Br J Dermatol, 2014,171（5）:1164⁃1171. doi: 10.1111/bjd.13138.
|
| ［11］ |
See JA, Gebauer K, Wu JK, et al. High patient satisfaction with daylight⁃activated methyl aminolevulinate cream in the treatment of multiple actinic keratoses: results of an observational study in Australia［J］. Dermatol Ther （Heidelb）, 2017,7（4）:525⁃533. doi: 10.1007/s13555⁃017⁃0199⁃9.
|
| ［12］ |
Calzavara⁃Pinton P, Zane C, Arisi M, et al. Evaluation of the costs of topical treatments for actinic keratosis based on lesion response and the affected area［J］. G Ital Dermatol Venereol, 2018,153（6）:764⁃775. doi: 10.23736/S0392⁃0488.18.06071⁃6.
|
| ［13］ |
Philipp⁃Dormston WG, Sanclemente G, Torezan L, et al. Daylight photodynamic therapy with MAL cream for large⁃scale photodamaged skin based on the concept of ′actinic field damage′: recommendations of an international expert group［J］. J Eur Acad Dermatol Venereol, 2016,30（1）:8⁃15. doi: 10.1111/jdv.13327.
|
| ［14］ |
See JA, Shumack S, Murrell DF, et al. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia［J］. Australas J Dermatol, 2016,57（3）:167⁃174. doi: 10.1111/ajd.12354.
|
| ［15］ |
Morton CA, Wulf HC, Szeimies RM, et al. Practical approach to the use of daylight photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: a European consensus［J］. J Eur Acad Dermatol Venereol, 2015,29（9）:1718⁃1723. doi: 10.1111/jdv.12974.
|
| ［16］ |
Wenande E, Phothong W, Bay C, et al. Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side⁃by⁃side, single⁃blind trial in patients with actinic keratosis and large⁃area field cancerization［J］. Br J Dermatol, 2019,180（4）:756⁃764. doi: 10.1111/bjd.17096.
|
| ［17］ |
Nissen CV, Heerfordt IM, Wiegell SR, et al. Pretreatment with 5⁃fluorouracil cream enhances the efficacy of daylight⁃mediated photodynamic therapy for actinic keratosis［J］. Acta Derm Venereol, 2017,97（5）:617⁃621. doi: 10.2340/00015555⁃2612.
|
| ［18］ |
Galimberti GN. Calcipotriol as pretreatment prior to daylight⁃mediated photodynamic therapy in patients with actinic keratosis: a case series［J］. Photodiagnosis Photodyn Ther, 2018,21:172⁃175. doi: 10.1016/j.pdpdt.2017.11.019.
|
| ［19］ |
Osman⁃Ponchet H, Sevin K, Gaborit A, et al. Lack of effect of selected sunscreens applied on ex vivo human skin for 5⁃methyl⁃aminolevulinic acid penetration and protoporphyrin IX photoactivation［J］. Photodiagnosis Photodyn Ther, 2017,17:75⁃81. doi: 10.1016/j.pdpdt.2016.11.012.
|
| ［20］ |
Ozog DM, Rkein AM, Fabi SG, et al. Photodynamic therapy: a clinical consensus guide［J］. Dermatol Surg, 2016,42（7）:804⁃827. doi: 10.1097/DSS.0000000000000800.
|
| ［21］ |
Räsänen JE, Neittaanmäki N, Ylitalo L, et al. 5⁃Aminolaevulinic acid nanoemulsion is more effective than methyl⁃5⁃aminolaevulinate in daylight photodynamic therapy for actinic keratosis: a nonsponsored randomized double⁃blind multicentre trial［J］. Br J Dermatol, 2019,181（2）:265⁃274. doi: 10.1111/bjd.17311.
|
| ［22］ |
Neittaanmäki⁃Perttu N, Karppinen TT, Tani T, et al. Long⁃term outcome of low⁃concentration hexyl⁃5⁃aminolaevulinate daylight photodynamic therapy for treatment of actinic keratoses［J］. Acta Derm Venereol, 2017,97（1）:120⁃121. doi: 10.2340/00015555⁃2484.
|
| ［23］ |
Vignion⁃Dewalle AS, Baert G, Thecua E, et al. Comparison of 10 efficient protocols for photodynamic therapy of actinic keratosis: how relevant are effective light dose and local damage in predicting the complete response rate at 3 months?［J］. Lasers Surg Med, 2018,50（5）:576⁃589. doi: 10.1002/lsm.22827.
|
| ［24］ |
Wiegell SR, Haedersdal M, Philipsen PA, et al. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single⁃blinded study［J］. Br J Dermatol, 2008,158（4）:740⁃746. doi: 10.1111/j.1365⁃2133.2008.08450.x.
|
| ［25］ |
Wiegell SR, Fabricius S, Stender IM, et al. A randomized, multicentre study of directed daylight exposure times of 1[12] vs. 2[12] h in daylight⁃mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp［J］. Br J Dermatol, 2011,164（5）:1083⁃1090. doi: 10.1111/j.1365⁃2133.2011.10209.x.
|
| ［26］ |
Wiegell SR, Fabricius S, Heydenreich J, et al. Weather conditions and daylight⁃mediated photodynamic therapy: protoporphyrin IX⁃weighted daylight doses measured in six geographical locations［J］. Br J Dermatol, 2013,168（1）:186⁃191. doi: 10.1111/j.1365⁃2133.2012.11200.x.
|
| ［27］ |
O′Mahoney P, Khazova M, Eadie E, et al. Measuring daylight: a review of dosimetry in daylight photodynamic therapy［J］. Pharmaceuticals （Basel）, 2019,12（4）:143. doi: 10.3390/ph1204 0143.
|
| ［28］ |
O′Gorman SM, Clowry J, Manley M, et al. Artificial white light vs daylight photodynamic therapy for actinic keratoses: a randomized clinical trial［J］. JAMA Dermatol, 2016,152（6）:638⁃644. doi: 10.1001/jamadermatol.2015.5436.
|
| ［29］ |
Gutiérrez García⁃Rodrigo C, Pellegrini C, Piccioni A, et al. Single versus two⁃treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: an intra⁃patient randomized trial［J］. Photodiagnosis Photodyn Ther, 2019,27:100⁃104. doi: 10.1016/j.pdpdt.2019.05. 031.
|
| ［30］ |
Gracia⁃Cazaña T, Malinis A, Almagro⁃Sánchez M, et al. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: an observational, prospective, comparative study［J］. Photodiagnosis Photodyn Ther, 2019,27:34⁃38. doi: 10.1016/j.pdpdt.2019.05.030.
|
| ［31］ |
Karrer S, Aschoff R, Dominicus R, et al. Methyl aminolevulinate daylight photodynamic therapy applied at home for non⁃hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany［J］. J Eur Acad Dermatol Venereol, 2019,33（4）:661⁃666. doi: 10.1111/jdv.15422.
|
